These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 12093310)

  • 1. Management options for cancer therapy-related anaemia.
    Littlewood TJ
    Drug Saf; 2002; 25(7):525-35. PubMed ID: 12093310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anaemia and its functional consequences in cancer patients: current challenges in management and prospects for improving therapy.
    Demetri GD
    Br J Cancer; 2001 Apr; 84 Suppl 1(Suppl 1):31-7. PubMed ID: 11308272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epoetin Beta: a review of its clinical use in the treatment of anaemia in patients with cancer.
    Cheer SM; Wagstaff AJ
    Drugs; 2004; 64(3):323-46. PubMed ID: 14871172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel uses for recombinant erythropoietin therapy in unlicensed indications.
    Macartney CA; Adgey AA; Jones FG; Morris TC; McMullin MF
    Hematol J; 2004; 5(2):181-5. PubMed ID: 15048070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant human erythropoietin in the treatment of cancer and chemotherapy-induced anemia: results of double-blind and open-label follow-up studies.
    Henry DH; Abels RI
    Semin Oncol; 1994 Apr; 21(2 Suppl 3):21-8. PubMed ID: 8202722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of erythropoietin on the reduction of blood transfusions and on survival of lung cancer patients receiving first-line chemotherapy.
    Fonseca PJ; Esteban E; de Vicente P; Luque M; Llorente B; Capelán M; Berros JP; Crespo G; Lacave AJ
    Clin Transl Oncol; 2008 Jul; 10(7):426-32. PubMed ID: 18628072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant human erythropoietin in cancer-related anemia. Review of clinical evidence.
    Crawford J
    Oncology (Williston Park); 2002 Sep; 16(9 Suppl 10):41-53. PubMed ID: 12380954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guidelines and recommendations for the management of anaemia in patients with lymphoid malignancies.
    Henry DH
    Drugs; 2007; 67(2):175-94. PubMed ID: 17284083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of anaemia in patients with malignancy: implications for the clinical use of recombinant human erythropoietin.
    Cazzola M
    Med Oncol; 2000 Nov; 17 Suppl 1():S11-6. PubMed ID: 11188780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythropoietin for the treatment of anemia associated with hematological malignancy.
    Littlewood TJ
    Hematol Oncol; 2001 Mar; 19(1):19-30. PubMed ID: 11276043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact and management of anaemia in haematological malignancies.
    Coiffier B
    Med Oncol; 2000 Nov; 17 Suppl 1():S2-10. PubMed ID: 11188782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The role of human recombinant erythropoietin in oncologic surgery].
    Mercuriali F
    Tumori; 1997; 83(4 Suppl 2):S16-9. PubMed ID: 9487379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy of rHuEPO in cancer-related anaemia.
    Samol J; Littlewood TJ
    Br J Haematol; 2003 Apr; 121(1):3-11. PubMed ID: 12670326
    [No Abstract]   [Full Text] [Related]  

  • 14. Epoetins and [symbol: see text] darbepoetin alfa in malignant disease.
    Drug Ther Bull; 2004 Mar; 42(3):21-3. PubMed ID: 15038080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant human erythropoietin in the treatment of cancer-related or chemotherapy-induced anaemia in patients with solid tumours.
    Nowrousian MR
    Med Oncol; 1998 Aug; 15 Suppl 1():S19-28. PubMed ID: 9785333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anaemia and cancer treatment: a conceptual change.
    Khan FA; Shukla AN; Joshi SC
    Singapore Med J; 2008 Oct; 49(10):759-64. PubMed ID: 18946607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of erythropoietin treatment on the quality of life of oncologic patients.
    Pelegrí A
    Clin Transl Oncol; 2007 Oct; 9(10):645-51. PubMed ID: 17974525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimizing the treatment of anemia in cancer patients. The role of a new erythropoietic agent.
    Henry DH
    Oncology (Williston Park); 2002 Oct; 16(10 Suppl 11):9-12. PubMed ID: 12435168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of erythropoietin in the treatment of lung cancer associated anaemia.
    Scagliotti GV; Novello S
    Lung Cancer; 2001 Dec; 34 Suppl 4():S91-4. PubMed ID: 11742710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anaemia management strategies: optimising treatment using epoetin beta (NeoRecormon).
    Glaspy J; Beguin Y
    Oncology; 2005; 69 Suppl 2():8-16. PubMed ID: 16244505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.